Combination hepatitis C virus antigen and antibody detection method

US9470686B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9470686-B2
Application numberUS-201414480978-A
CountryUS
Kind codeB2
Filing dateSep 9, 2014
Priority dateSep 1, 2006
Publication dateOct 18, 2016
Grant dateOct 18, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An in vitro method that allows detection of hepatitis C by detecting hepatitis C virus (HCV) core protein and antibodies to HCV core protein (anti-core antibodies) in a single assay is provided. Cross-reactivity is eliminated in the method preferably by utilizing short peptides, each of which has an amino acid sequence that corresponds to an immunodominant region of the native core protein but which does not wholly encompass the epitope bound by the antibodies utilized in the method. The method can be used to detect the presence of HCV in a subject, and/or to determine the suitability of donor blood or blood products for transfusion purposes. Also provided are diagnostic kits for carrying out the method and a process for selecting suitable capture peptides and monoclonal antibodies for use in the combination method.

First claim

Opening claim text (preview).

What is claimed is: 1. A kit for detection of hepatitis C core protein and antibodies to hepatitis C core protein in a sample, said kit comprising: a first capture peptide consisting of SEQ ID NO:4, a second capture peptide consisting of SEQ ID NO:3 or SEQ ID NO:54 and a third capture peptide consisting of SEQ ID NO:5, and one or more antibodies, wherein a first of said one or more antibodies specifically binds to a first epitope of hepatitis C core protein, wherein said first epitope is different from the epitopes comprised by said capture peptides. 2. The kit according to claim 1 , wherein said one or more antibodies are monoclonal antibodies. 3. The kit according to claim 1 , wherein said first epitope has a sequence as set forth in SEQ ID NO:6 or 98. 4. The kit according to claim 1 , further comprising a non-core protein of hepatitis C virus.

Assignees

Inventors

Classifications

  • Hepatitis C virus; GB virus C [GBV-C] · CPC title

  • Detection of antibodies in sample from host which are directed against antigens from microorganisms · CPC title

  • Detection of antigens from microorganism in sample from host · CPC title

  • Hepatitis C; Hepatitis NANB · CPC title

  • Anti-idiotype · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9470686B2 cover?
An in vitro method that allows detection of hepatitis C by detecting hepatitis C virus (HCV) core protein and antibodies to HCV core protein (anti-core antibodies) in a single assay is provided. Cross-reactivity is eliminated in the method preferably by utilizing short peptides, each of which has an amino acid sequence that corresponds to an immunodominant region of the native core protein but …
Who is the assignee on this patent?
Abbott Lab
What technology area does this patent fall under?
Primary CPC classification G01N33/56983. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).